SCHEMBL27361867

SCHEMBL27361867

CC(=O)Oc1cc(C)on1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.49
NPC1 O15118 5/20 0.49
TMPRSS15 P98073 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.42
MAPT P10636 2/20 0.42
ALDH1A1 P00352 8/20 0.41
HTT P42858 2/20 0.41
TP53 P04637 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
AGTR1 P30556 1/20 0.41
LMNA P02545 1/20 0.41
GFER P55789 1/20 0.41
EGFR P00533 1/20 0.40
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM3 P20309 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL875579 0.84 TMPRSS15 (0.49) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL6632393 0.82 TMPRSS15 (0.55) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL8305554 0.82 TMPRSS15 (0.48) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL9844093 0.81 TMPRSS15 (0.47) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL19520914 0.79 TMPRSS15 (0.49) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL27952188 0.78 TMPRSS15 (0.45) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL23723952 0.77 TMPRSS15 (0.47) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL836787 0.76 L3MBTL1 (0.56) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL22978691 0.73 TSHR (0.49) RAB9ANPC1TMPRSS15L3MBTL1MAPT
SCHEMBL27810220 0.72 ALDH1A1 (0.56) RAB9ANPC1MAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111051304-B Imidazo [4,5-c ] quinoline derivatives as LRRK2 inhibitors 辉瑞大药厂 2022-12-27 CN disclosed
CN-113330000-A 3-carbonylamino-5-cyclopentyl-1 FI-pyrrole compound having inhibitory activity against CDK2 辉瑞公司 2021-08-31 CN disclosed
CN-101405294-B Compounds for Enzyme Inhibition ONYX THERAPEUTICS, INC. (US) 2015-11-25 CN disclosed
CN-101087794-B Pharmaceutical compounds HOFFMANN LA ROCHE 2011-05-18 CN disclosed
CN-101868457-A (3-hydroxy-4-amino-but-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for use in therapy COMENTIS INC 2010-10-20 CN disclosed
CN-100543017-C Keto-oxadiazole derivatives as cathepsin inhibitors AVENTIS PHARMA INC (US) 2009-09-23 CN disclosed
CN-100528846-C Amine compounds and use thereof KUREHA CHEMICAL IND CO LTD (JP) 2009-08-19 CN disclosed
CN-101405294-A Compounds for enzyme inhibition PROTEOLIX INC (US) 2009-04-08 CN disclosed
CN-1898219-A Novel keto-oxadiazole derivatives as cathepsin inhibitors AVENTIS PHARMA INC (US) 2007-01-17 CN disclosed
CN-1646495-A Amine compounds and use thereof KUREHA CHEMICAL IND CO LTD (JP) 2005-07-27 CN disclosed
CN-1068316-C Process for synthesizing 5-methyl-isoxazole-3-carboxamide KUNSHAN GENERAL PHARMACEUTICAL (CN) 2001-07-11 CN disclosed
CN-1156723-A Process for synthesizing 5-methyl-isoxazole-3-carboxamide KUNSHAN GENERAL PHARMACEUTICAL (CN) 1997-08-13 CN disclosed